Product List

Generic:

Dexlansoprazole

Therapeutic Class:

Proton Pump Inhibitor

Composition:

Description:

Daplazole (Dexlansoprazole) belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H+, K+)-ATPase at the secretory surface of the gastric parietal cell.

Indications:

Healing of Erosive Esophagitis:

Indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks.

Maintenance of Healed Erosive Esophagitis and Relief of Heartburn: 

Indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age.

Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease:

Indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD) for four weeks

Dosage:

• Recommended Dosage Regimen by Indication in Patients 12 Years of Age and Older
  

  Indication	Dosage	Duration
  Healing of Erosive Esophagitis	One 60 mg capsule once daily.	Up to 8 weeks
  Maintenance of Healed Erosive Esophagitis and Relief of Heartburn	One 30 mg capsule once daily	Controlled studies did not extend beyond 6 months in adults and 16 weeks in patients 12 to 17 years of age.
  Symptomatic Non-Erosive Gastroesophageal Reflux Disease	One 30 mg capsule once daily.	4 weeks

Presentations:

• Daplazole Caps 30 mg & 60 mg are available in pack of 30’s